Compound Detail
CHEMBL144521
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
NC[C@H]1[C@@H](O)[C@H](n2cnc3c(NCc4cccc(I)c4)ncnc32)O[C@@H]1CO
Basic Information
| ChEMBL ID | CHEMBL144521 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WNYCSKXAMBKIQP-HOPMXRPOSA-N |
2
Targets
12
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
496.3
MW (Da)
0.87
ALogP
9
HBA
4
HBD
131.3
PSA (Ų)
0.37
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Ki 12 meas. best 8.19
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adenosine receptor A2a CHEMBL251 | Ki | 8.19 | 7.3386 | 6.5 | 7 |
| Adenosine receptor A3 CHEMBL256 | Ki | 6.21 | 5.454 | 610.0 | 5 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 14584936 | 10.1021/jm0300431 | Adenosine receptor A2a | 7 |
| 16640329 | 10.1021/jm050968b | Adenosine receptor A3 | 6 |
Data from ChEMBL 36 via Core Engine